As is reported in prostate cancer, CCND2 promoter methylation was more frequently observed in high Gleason score tumors [23] and was associated with tumor development in prostate [24].However, the expression of CCND2 and the regulation mechanism underlying renal cell cancer has not been reported before. The gene discussed is CCND2; the disease is renal cell adenocarcinoma.